Ra Capital Management, L.P. Verastem, Inc. Transaction History

Ra Capital Management, L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$1.15 - $2.4 $9.28 Million - $19.4 Million	-8,066,171 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$1.11 - $1.68 $1.18 Million - $1.79 Million	-1,063,080 Reduced 11.64%	8,066,171 $9.76 Million
Q2 2020 Aug 14, 2020	SELL	$1.69 - $4.2 $16 Million - $39.8 Million	-9,475,400 Reduced 50.93%	9,129,251 $15.7 Million
Q1 2020 May 15, 2020	BUY	$1.26 - $3.38 $23.4 Million - $62.9 Million	18,604,651 New	18,604,651 $49.1 Million

297K

Ticker VSTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 210,000,000
Market Cap $1.25B
Description
Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylat...

Get notified when there are updates to the investment portfolio of Ra Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Ra Capital Management, L.P. with notifications on news.